XPNPEP1

From WikiProjectMed
Jump to navigation Jump to search
XPNPEP1
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesXPNPEP1, APP1, SAMP, XPNPEP, XPNPEPL, XPNPEPL1, X-prolyl aminopeptidase (aminopeptidase P) 1, soluble, X-prolyl aminopeptidase 1
External IDsOMIM: 602443 MGI: 2180003 HomoloGene: 6424 GeneCards: XPNPEP1
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_133216
NM_001374834

RefSeq (protein)

NP_573479

Location (UCSC)Chr 10: 109.86 – 109.92 MbChr 19: 52.92 – 53.03 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Xaa-Pro aminopeptidase 1 is an enzyme that in humans is encoded by the XPNPEP1 gene.[5]

Function

X-prolyl aminopeptidase (EC 3.4.11.9) is a proline-specific metalloaminopeptidase that specifically catalyzes the removal of any unsubstituted N-terminal amino acid that is adjacent to a penultimate proline residue. Because of its specificity toward proline, it has been suggested that X-prolyl aminopeptidase is important in the maturation and degradation of peptide hormones, neuropeptides, and tachykinins, as well as in the digestion of otherwise resistant dietary protein fragments, thereby complementing the pancreatic peptidases. Deficiency of X-prolyl aminopeptidase results in excretion of large amounts of imino-oligopeptides in urine (Blau et al., 1988).[supplied by OMIM][5]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000108039Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000025027Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b "Entrez Gene: XPNPEP1 X-prolyl aminopeptidase (aminopeptidase P) 1, soluble".

Further reading

  • Vanhoof G, De Meester I, Goossens F, Hendriks D, Scharpé S, Yaron A (Aug 1992). "Kininase activity in human platelets: cleavage of the Arg1-Pro2 bond of bradykinin by aminopeptidase P". Biochemical Pharmacology. 44 (3): 479–87. doi:10.1016/0006-2952(92)90439-P. PMID 1510698.
  • Blau N, Niederwieser A, Shmerling DH (1988). "Peptiduria presumably caused by aminopeptidase-P deficiency. A new inborn error of metabolism". Journal of Inherited Metabolic Disease. 11 (Suppl 2): 240–2. doi:10.1007/BF01804246. PMID 3141711. S2CID 32596444.
  • Maruyama K, Sugano S (Jan 1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
  • Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (Oct 1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
  • Vanhoof G, Goossens F, Juliano MA, Juliano L, Hendriks D, Schatteman K, Lin AH, Scharpé S (1998). "Isolation and sequence analysis of a human cDNA clone (XPNPEPL) homologous to X-prolyl aminopeptidase (aminopeptidase P)". Cytogenetics and Cell Genetics. 78 (3–4): 275–80. doi:10.1159/000134671. PMID 9465902.
  • Sprinkle TJ, Caldwell C, Ryan JW (Jun 2000). "Cloning, chromosomal sublocalization of the human soluble aminopeptidase P gene (XPNPEP1) to 10q25.3 and conservation of the putative proton shuttle and metal ligand binding sites with XPNPEP2". Archives of Biochemistry and Biophysics. 378 (1): 51–6. doi:10.1006/abbi.2000.1792. PMID 10871044.
  • Cottrell GS, Hooper NM, Turner AJ (Dec 2000). "Cloning, expression, and characterization of human cytosolic aminopeptidase P: a single manganese(II)-dependent enzyme". Biochemistry. 39 (49): 15121–8. doi:10.1021/bi001585c. PMID 11106490.
  • Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J (May 2003). "Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides". Nature Biotechnology. 21 (5): 566–9. doi:10.1038/nbt810. PMID 12665801. S2CID 23783563.